Covid drug Remdesivir under brand name Covifor in India launch By Hetero
Hyderabad-based Hetero Labs on Sunday said it had received regulatory approval to manufacture and market antiviral drug remdesivir for treating patients.Hetero's generic version of remdesivir will be marketed under the brand name 'Covifor' in India, said the company after getting approval from the Drug Controller General of India.
In the light of increasing Covid-19 cases in India, the approval of Covifor (Remdesivir) can prove to be a game-changer given its positive clinical outcomes. Backed by strong backward integration capabilities, we can ensure that the product is immediately made available to patients across the country," said B Partha Saradhi Reddy, chairman of Hetero Group Of Companies.Partha Saradhi Reddy said that the company will ensure enough stocks to cater to present needs.Hetero had earlier told Business Standard that it had the active pharmaceutical ingredients (API) to make one million doses of remdesivir for starters. It is fully vertically integrated and would also make the key starting material (KSM) for the drug.